• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Investigating the eye-kidney connection via OCT retinal scans


The kidney and eye are structurally and functionally similar, and the diseases of the organs may present similarly and via common pathways.

OCT retinal scans reveal eye kidney connection - Image credit: Adobe Stock / focusandblur

(Image credit: Adobe Stock / focusandblur)

UK investigators identified a link between the findings in the eye seen on optical coherence tomography (OCT) scans and patients with chronic kidney disease.1 Lead author led by Tariq E. Farrah, BM, BSc, is from Edinburgh Kidney, University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, and the Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.

The research team pointed out the need for novel biomarkers that reliably track kidney injury, demonstrate a treatment response, and predict outcomes in patients with chronic kidney disease (CKD). This knowledge would be useful in optometric practices to participate in the care of patients with CKD.

They also explained the rationale for the eye-kidney connection. The kidney and eye are structurally and functionally similar,2,3 and the diseases of the organs may present similarly and via common pathways. They offered the evidence that Bruch’s membrane and the glomerular basement membrane both have a network of α3, α4 and α5 type IV collagen chains.4,5 Thus, type IV collagen inherited disease manifests with both nephropathy and retinopathy, as in Alport syndrome.6

Farrah and associates investigated the potential of retinal OCT imaging to reliably track kidney injury, monitor treatment responses, and predict outcomes in a series of prospective studies of patients with CKD who did not yet require dialysis. These 204 participants included those who underwent a kidney transplantation, had kidney failure and were undergoing kidney transplantation, living kidney donors, and 86 healthy volunteers.

The investigators reported that compared to healthy volunteers, “We observed similar retinal thinning and reduced macular volume in patients with CKD and in those with a kidney transplant. However, the choroidal thinning observed in CKD was not seen in patients with a kidney transplant, whose choroids resemble those of healthy volunteers. In CKD, the degree of choroidal thinning is related to the falling estimated glomerular filtration rate (eGFR) and extent of kidney scarring. Following kidney transplantation, choroidal thickness increases rapidly (~10%) and is maintained over 1 year, whereas gradual choroidal thinning is seen during the 12 months following kidney donation. In patients with CKD, the retinal and choroidal thicknesses are independently associated with eGFR decline over 2 years.”

Based on their findings, the researchers concluded that retinal OCT images can non-invasively be a monitor and prognostic biomarker of kidney injury.

1. Farrah TE, Pugh D, Chapman FA, et al. Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatment. Nat Commun. 2023;14:7720; https://doi.org/10.1038/s41467-023-43125-1
2. Wong CW, Wong TY, Cheng C.Y, Sabanayagam C. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney Int. 2014;85:1290–1302.
3. Farrah TE, Dhillon B, Keane PA, Webb DJ, Dhaun N. The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons. Kidney Int. https://doi.org/10.1016/j.kint.2020.01.039 (2020).
4. Booij JC, Baas DC, Beisekeeva J, Gorgels TGMF, Bergen, AAB. The dynamic nature of Bruch’s membrane. Prog Retin Eye Res 2010;9:1–18.
5. Boutaud A, Borza DB, Bondar O, et al. Type IV collagen of the glomerular basement membrane. J Biol Chem. 2000;275:30716–30724.
6. Savige J, Sheth S, Leys A, et al. Ocular features in Alport’s syndrome: pathogenesis and clinical significance. Clin J Am Soc Nephrol. 2015;10:703–709.
Related Videos
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.